Speaker Bio
Prof McLaughlin, a physicist, and a Fellow of the Inst. of Physics has developed significant initiatives within research, technology transfer, outreach and teaching over these past 30 years. Presently, as a Professor he is the Director of the Engineering Research Institute and Director of NIBEC. His salient disciplines address Digital Healthcare Technology and related bio-sensing applications. He was awarded in 2012 an OBE for his services to Research and Economic Development in Northern Ireland, as well a numerous research and innovation awards. In 2022 he was further awarded with a CBE for Research and Education in Northern Ireland. He has attained in excess of three hundred publications (H index 50) and he has been honoured as an invited speaker at over sixty International Conferences and he has attracted over £50M of high quality funding from bodies such as EPSRC, Wellcome Trust, EU, NSF, Royal Soc., DoE; Invest NI as well as industry.
In recent years his over-arching strategy is to develop a strong CH Platform within N.Ireland and the EU. This work involves linking bioengineering and computing sciences with sensor technology developed within NIBEC and thus facilitating clinically-led research initiatives to benefit the healthcare sector. Affiliated Centres have now been set up including CHIC, ECME, Biodevices Lab, CACR and the new Healthcare Technology Hub.
A holder of over 35 patents, including one for the world’s best selling disposable medical electrode, he has successfully co-founded a set of spin-out companies including the highly successful CH company - Intelesens Ltd and SiSaf Ltd. He has held positions on committees such: RAE 2008 Materials Panel; a Matrix Panel chair; EPSRC College; NanoIreland Task Force/Chaired the Nanomaterials Panel; Adv. panel to MSSI; Chair of European CH Campus; InnovateUK KTN Health Technologies Adv. Panel and NI TechStart. He is currently a Director on the board of IUL Ltd and ECHA
Notable recent achievements include leading a 2017 Qualcomm Xprize Tricorder Team to joint third place (out of 360); 2017 Healthcare NI Innovation Award; Distinguished Research(2013) and Impact (2016) Awards etc.